REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...
ROSWELL, Ga., Jan. 14, 2019 /PRNewswire-PRWeb/ -- The Centers for Disease Control (CDC) has updated information related to the use and availability of VARIZIG® (Varicella Zoster Immune Globulin [Human ...
(RTTNews) - Kamada Ltd. (KMDA), a biopharmaceutical company specializing in rare and serious conditions, announced on Monday that it has been awarded a three-year contract with an international ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback